Cargando…
A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation
A coronavirus SARS-CoV-2, which has caused the pandemic viral pneumonia disease COVID-19, significantly threatens global public health, highlighting the need to develop effective and safe vaccines against its infection. In this study, we developed a novel DNA vaccine candidate against SARS-CoV-2 by...
Autores principales: | Jeong, Hyein, Choi, Yu-Min, Seo, Hyejun, Kim, Bum-Joon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959807/ https://www.ncbi.nlm.nih.gov/pubmed/33732258 http://dx.doi.org/10.3389/fimmu.2021.637654 |
Ejemplares similares
-
Recombinant Mycobacterium smegmatis delivering a fusion protein of human macrophage migration inhibitory factor (MIF) and IL-7 exerts an anticancer effect by inducing an immune response against MIF in a tumor-bearing mouse model
por: Jeong, Hyein, et al.
Publicado: (2021) -
Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections
por: Kim, Byoung-Jun, et al.
Publicado: (2021) -
Potential of Mycobacterium tuberculosis chorismate mutase (Rv1885c) as a novel TLR4-mediated adjuvant for dendritic cell-based cancer immunotherapy
por: Jeong, Hyein, et al.
Publicado: (2022) -
Novel domain combinations in proteins encoded by chimeric transcripts
por: Frenkel-Morgenstern, Milana, et al.
Publicado: (2012) -
Peptides fused to the amino-terminal end of diphtheria toxin are translocated to the cytosol
Publicado: (1991)